129 related articles for article (PubMed ID: 35446298)
1. Perihippocampal failure after hippocampal-avoidance whole-brain radiotherapy in cancer patients with brain metastases: Results of a retrospective analysis.
Shieh LT; Lee SW; Chen CC; Ho YC; Wang YW; Ho SY
Medicine (Baltimore); 2022 Apr; 101(14):e29144. PubMed ID: 35446298
[TBL] [Abstract][Full Text] [Related]
2. Verification of Low Risk for Perihippocampal Recurrence in Patients with Brain Metastases Who Received Whole-Brain Radiotherapy with Hippocampal Avoidance.
Kim Y; Kim SH; Lee JH; Kang DG
Cancer Res Treat; 2019 Apr; 51(2):568-575. PubMed ID: 30011983
[TBL] [Abstract][Full Text] [Related]
3. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
[TBL] [Abstract][Full Text] [Related]
4. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of hippocampal avoidance whole brain radiation in patients with hippocampal involvement: Data from a prospective study.
Lee G; Besse L; Lamba N; Hancox C; Usta I; Hacker F; Catalano P; Brown PD; Tanguturi S; Pashtan I; Phillips J; Haas-Kogan D; Alexander B; Cagney D; Aizer A
Med Dosim; 2021 Spring; 46(1):21-28. PubMed ID: 32778521
[TBL] [Abstract][Full Text] [Related]
6. Automated contouring and planning pipeline for hippocampal-avoidant whole-brain radiotherapy.
Feng CH; Cornell M; Moore KL; Karunamuni R; Seibert TM
Radiat Oncol; 2020 Oct; 15(1):251. PubMed ID: 33126894
[TBL] [Abstract][Full Text] [Related]
7. Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases.
Lebow ES; Hwang WL; Zieminski S; Wang Y; Niemierko A; Mehan WA; Oh KS; Khandekar M; Willers H; Shih HA
J Neurooncol; 2020 May; 148(1):81-88. PubMed ID: 32307637
[TBL] [Abstract][Full Text] [Related]
8. Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases.
Popp I; Rau S; Hintz M; Schneider J; Bilger A; Fennell JT; Heiland DH; Rothe T; Egger K; Nieder C; Urbach H; Grosu AL
Cancer; 2020 Jun; 126(11):2694-2703. PubMed ID: 32142171
[TBL] [Abstract][Full Text] [Related]
9. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
[TBL] [Abstract][Full Text] [Related]
10. Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: A systematic review and meta-analysis.
Wiegreffe S; Sarria GR; Layer JP; Dejonckheere E; Nour Y; Schmeel FC; Anton Giordano F; Schmeel LC; Popp I; Grosu AL; Gkika E; Stefaan Dejonckheere C
Radiother Oncol; 2024 May; 197():110331. PubMed ID: 38772476
[TBL] [Abstract][Full Text] [Related]
11. Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933.
Gondi V; Tome WA; Marsh J; Struck A; Ghia A; Turian JV; Bentzen SM; Kuo JS; Khuntia D; Mehta MP
Radiother Oncol; 2010 Jun; 95(3):327-31. PubMed ID: 20392503
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Hippocampal Avoidance Whole Brain Radiotherapy on the Preservation of Long-Term Neurocognitive Function in Non-Small Cell Lung Cancer Patients With Brain Metastasis.
Wang B; Fu S; Huang Y; Liu L; Liang Y; An W; Fan Y; Zhao Y
Technol Cancer Res Treat; 2021; 20():15330338211034269. PubMed ID: 34396867
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
Brown PD; Gondi V; Pugh S; Tome WA; Wefel JS; Armstrong TS; Bovi JA; Robinson C; Konski A; Khuntia D; Grosshans D; Benzinger TLS; Bruner D; Gilbert MR; Roberge D; Kundapur V; Devisetty K; Shah S; Usuki K; Anderson BM; Stea B; Yoon H; Li J; Laack NN; Kruser TJ; Chmura SJ; Shi W; Deshmukh S; Mehta MP; Kachnic LA;
J Clin Oncol; 2020 Apr; 38(10):1019-1029. PubMed ID: 32058845
[TBL] [Abstract][Full Text] [Related]
15. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.
Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y
Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773
[TBL] [Abstract][Full Text] [Related]
16. Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions.
Wang X; Chen J; Lei Z; Chen H; Zhang Y; Liu G; Li S; Zheng Z; Wang H
BMC Cancer; 2023 Aug; 23(1):796. PubMed ID: 37620791
[TBL] [Abstract][Full Text] [Related]
17. Analyses of distribution and dosimetry of brain metastases in small cell lung cancer with relation to the neural stem cell regions: feasibility of sparing the hippocampus in prophylactic cranial irradiation.
Zhao L; Shen Y; Guo JD; Gu HL; Yu W; Wang JM; Lv CX; Liu J; Cai XW; Fu XL
Radiat Oncol; 2017 Jul; 12(1):118. PubMed ID: 28709456
[TBL] [Abstract][Full Text] [Related]
18. Incidence and relapse risk of intracranial metastases within the perihippocampal region in 314 patients with breast cancer.
Sun B; Huang Z; Wu S; Shen G; Cha L; Meng X; Ding L; Wang J; Song S
Radiother Oncol; 2016 Jan; 118(1):181-6. PubMed ID: 26674923
[TBL] [Abstract][Full Text] [Related]
19. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival.
Oehlke O; Wucherpfennig D; Fels F; Frings L; Egger K; Weyerbrock A; Prokic V; Nieder C; Grosu AL
Strahlenther Onkol; 2015 Jun; 191(6):461-9. PubMed ID: 25592907
[TBL] [Abstract][Full Text] [Related]
20. Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy.
Harth S; Abo-Madyan Y; Zheng L; Siebenlist K; Herskind C; Wenz F; Giordano FA
Radiother Oncol; 2013 Oct; 109(1):152-8. PubMed ID: 24100152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
